Posted Gio, 29/10/2009 - 17:25 by Redazione
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b (under review)
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma World J Hepatol 2011 November 27; 3(11): 278-284 ISSN 1948-5182 (online)© 2011
Rapid virological response as predictor of sustained response in HCV carriers with persistently normal alanine aminotransferase levels. A multicentric study. J Viral Hepat. 2010 Jun 8. [Epub ahead of print]
Comparison of peginterferon alfa-2a and ribavirin for 12 or 24 weeks in patients with HCV genotype 2 or 3: the CLEO trial. BMC Gastrenterology 2010 Feb 19;10(1):21. [Epub ahead of print] PMID: 20170514 [PubMed - as supplied by publisher]
Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study. Liver Int. 2009 Nov;29(10):1479-84. Epub 2009 Apr 28. PMID: 19422478 [PubMed - in process]
Adefovir and Lamivudine in combination compared to Adefovir alone in HBeAg-negative chronic Hepatitis B patients wiyh clinical resistance to Lamivudine: a multicenter retrospective study. Clin Ther. 2008 Feb;30(2):317-23.PMID: 18343270 [PubMed - indexed for MEDLINE]
Management of chronic hepatitis in drug addicts: a systematic review. Clin Ter. 2008 Jan-Feb;159(1):41-9. Review.PMID: 18399262 [PubMed - indexed for MEDLINE]
